---
title: "YSB Inc. (09885.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/09885.HK.md"
symbol: "09885.HK"
name: "YSB Inc."
industry: "Health Care Distributors"
---

# YSB Inc. (09885.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Location | HK Market |
| Website | [www.ysbang.cn](https://www.ysbang.cn) |

## Company Profile

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: B (0.37)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 21 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.42% |  |
| Net Profit YoY | 7085.42% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.33 |  |
| Dividend Ratio | 1.63% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.38B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 20.53B |  |


**Multi Score**: B

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.97% | C |
| Profit Margin | 0.46% | C |
| Gross Margin | 11.22% | E |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.42% | C |
| Net Profit YoY | 7085.42% | A |
| Total Assets YoY | 29.98% | A |
| Net Assets YoY | 17.23% | A |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 21935.20% | A |
| OCF YoY | 6.42% | C |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 3.13 | A |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 66.45% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - YSB Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.97%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "0.46%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "11.22%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "6.42%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "7085.42%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "29.98%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "17.23%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "21935.20%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "6.42%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "3.13",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "66.45%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | GUANZE MEDICAL (HK.2427) | B | A | C | A | B | B |
| 02 | YSB (HK.9885) | C | B | A | D | B | B |
| 03 | GBG HOLDINGS (HK.8372) | B | B | B | A | B | B |
| 04 | SH PHARMA (HK.2607) | C | C | A | D | B | C |
| 05 | BAIYUNSHAN PH (HK.874) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 35.74 | 10/23 | 201.75 | 85.28 | 45.56 |
| PB | 1.33 | 14/23 | 2.68 | 2.15 | 1.64 |
| PS (TTM) | 0.16 | 6/23 | 0.34 | 0.27 | 0.20 |
| Dividend Yield | 1.63% | 8/23 | 1.38% | 0.88% | 0.80% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-09-27T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.94 |

## References

- [Company Overview](https://longbridge.com/en/quote/09885.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/09885.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/09885.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.